Alisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Gilead Sciences
Weill Medical College of Cornell University
Swiss Cancer Institute
Milton S. Hershey Medical Center
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)
Augusta University
Amgen
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)